Medical technology message in WHO mental health campaign
This article was originally published in Clinica
The (WHO) has launched a campaign to highlight the unmet service needs of mental health, calling for this to be made a far bigger investment priority. The initiative is targeted at low- and middle-income countries, but as brain imaging gains credence as a key early diagnostic/theranostic and therapy monitoring tool, with important clinical- and cost-effectiveness implications, it also underlines medtech investment needs in developed health systems.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.